Figure 2.
Distribution of aGVHD scores in the validation cohort. Distributions of aGVHD prediction scores calculated by the ADTree model are displayed for grade II-IV aGVHD (A) and grade III-IV aGVHD (B) among patients in the validation cohort (n = 8050). Higher values indicate a higher risk for developing aGVHD.